Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News BioNexus Gene Lab Corporation BGLC

BioNexus Gene Lab Corp., through its subsidiaries, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. The company operates through three segments: Trading of Industrial Chemicals; Provision for Genomic Screening Services;... see more

Current News (NDAQ:BGLC)

BioNexus Gene Lab Corp. Completes Strategic Investment in Fidelion Diagnostics; Secures 15% Equity Stake in Global AI-Oncology Platform and Exclusive Southeast Asian Rights for VitaGuard(TM)

GlobeNewswire December 3, 2025

BioNexus Gene Lab Corp. (Nasdaq: BGLC) Secures $500 Million Equity Facility From ARC Group International to Support Expansion of Precision Diagnostics, CDMO Operations, and Therapeutic Commercialization

GlobeNewswire December 2, 2025

BioNexus Gene Lab Corp. (Nasdaq: BGLC) and Fidelion Diagnostics Execute Exclusive Southeast Asia License for VitaGuard(TM) MRD Platform as Part of Strategic Alliance with Tongshu Gene

GlobeNewswire December 1, 2025

BioNexus Gene Lab Corp. (Nasdaq: BGLC) Announces Strategic Agreements with Fidelion Diagnostics for Southeast Asia MRD Commercialization

GlobeNewswire November 12, 2025

BioNexus Gene Lab Corp. Files $100 Million Shelf Registration and Establishes $20 Million At-the-Market Program to Advance Strategic Growth Opportunities

GlobeNewswire November 10, 2025

BioNexus Gene Lab Corp Signs Strategic Partnership Term Sheet with BirchBioMed Inc.

GlobeNewswire October 20, 2025

BioNexus Gene Lab Corp. and Fidelion Diagnostics Announce Landmark Alliance-Touted as a new "DeepSeek Moment" in Precision Oncology

GlobeNewswire July 30, 2025

BioNexus Gene Lab Corp. Regains Nasdaq Compliance, Signaling Strategic Stability and Growth Readiness

GlobeNewswire April 30, 2025

BioNexus Gene Lab Corp. Files 2024 Annual Report Highlighting Strategic Innovation, Operational Resilience, and Growth Trajectory

GlobeNewswire April 15, 2025

Opinion & Analysis (NDAQ:BGLC)

No current opinion is available.

Bullboard Posts (NDAQ:BGLC)

Using technical analysis for this stock.

It is signalling a big uptrend for shareholders today
coolfooldumbguy - July 17, 2025

Buy buddy buy.

Otherwise FOMO
coolfooldumbguy - July 1, 2025

RE:BGLC...Post RS..higher highs & higher lows = Trend change

LoL....just as I was posting BGLC poppped over $5.00 / sh and SBET also popped over $107.00 / sh I would say that if BGLC breaks $5.20.....
Iseneschal - May 30, 2025

BGLC...Post RS..higher highs & higher lows = Trend change

And it's a sympathy play for SBET which is trading over $100.00 / sh Both are Ethereum plays
Iseneschal - May 30, 2025

Buy buddy buy because it's taking off this morning.

Otherwise you guys will be missing out on the big uptrend
coolfooldumbguy - April 11, 2025

RE:BGLC ....RS voted on & approved

If u didn't heed my warning your only down ~30%.......you got lots of money....no problem ; )
Iseneschal - March 27, 2025

Podcasts